These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. FK506: therapeutic effects on lupus dermatoses in autoimmune-prone MRL/Mp-lpr/lpr mice. Furukawa F; Imamura S; Takigawa M Arch Dermatol Res; 1995; 287(6):558-63. PubMed ID: 7487142 [TBL] [Abstract][Full Text] [Related]
7. Early induction of anti-double-stranded DNA antibodies in lupus-prone MRL mice inoculated with Ly-24+ cells cloned from lymph node cells of an MRL/Mp-lpr/lpr mouse: possible effect of putative cytokines produced by cloned Ly-24+ cells. Kanai Y; Isonishi S; Katagiri T; Koizumi T; Miura K; Kurosawa Y Immunol Lett; 1990; 24(1):49-55. PubMed ID: 2197220 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice. Yang J; Li Q; Yang X; Li M Mol Med; 2015 Apr; 21(1):364-70. PubMed ID: 25902303 [TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of lupus dermatoses in autoimmune mice. IV. Association between cutaneous immunoglobulin deposition and anti-single-stranded DNA antibodies in sera. Furukawa F; Kohno A; Ohshio G; Suzuki K; Hamashima Y Arch Dermatol Res; 1985; 277(2):79-83. PubMed ID: 3885874 [TBL] [Abstract][Full Text] [Related]
12. An epistatic effect of the female specific loci on the development of autoimmune vasculitis and antinuclear autoantibody in murine lupus. Zhang MC; Misu N; Furukawa H; Watanabe Y; Terada M; Komori H; Miyazaki T; Nose M; Ono M Ann Rheum Dis; 2006 Apr; 65(4):495-500. PubMed ID: 16150787 [TBL] [Abstract][Full Text] [Related]
13. [Effects of HS1-associated protein X-1 on the lupus activities: experiment with MRL/lpr lupus-like mice]. Zhai ZF; Zhou CL; Zhong BY; Ao JH; Hao F Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):406-10. PubMed ID: 18581896 [TBL] [Abstract][Full Text] [Related]
14. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011 [TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of non-depleting anti-CD4 in MRL/Mp-lpr/lpr mice with active systemic lupus erythematosus and microscopic angiitis. Harper JM; Cook A Autoimmunity; 2001; 33(4):245-51. PubMed ID: 11683399 [TBL] [Abstract][Full Text] [Related]
17. Induction of autoantibodies in normal mice by injection of nucleobindin and natural occurrence of antibodies against nucleobindin in autoimmune MRL/lpr/lpr mice. Kanai Y; Takeda O; Miura K; Amagai M; Kaneko T; Kubota T; Kanai Y; Tanuma S; Kurosawa Y Immunol Lett; 1995 Feb; 45(1-2):35-42. PubMed ID: 7622185 [TBL] [Abstract][Full Text] [Related]
18. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice. Sadanaga A; Nakashima H; Akahoshi M; Masutani K; Miyake K; Igawa T; Sugiyama N; Niiro H; Harada M Arthritis Rheum; 2007 May; 56(5):1618-28. PubMed ID: 17469144 [TBL] [Abstract][Full Text] [Related]
19. Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr mice. Yan SX; Deng XM; Wang QT; Sun XJ; Wei W Acta Pharmacol Sin; 2015 Nov; 36(11):1367-76. PubMed ID: 26456588 [TBL] [Abstract][Full Text] [Related]
20. Auto-MHC class II-reactive T cell line obtained from MRL/+ mice suffering from lpr-GVHD. II. Analyses of functional characteristics of T cell line by in vivo administration. Nagata N; Nakagawa T; Hosaka N; Ikehara S Immunobiology; 1992 Nov; 186(5):339-50. PubMed ID: 1286875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]